Double Your Impact in the Fight Against Alzheimer's
Double Your Impact in the Fight Against Alzheimer's
The Power Our Progress 2x Match is happening right now. Your gift before Nov. 15 can make twice the impact on our work to advance research, promote brain health, and help provide care and support for those impacted by Alzheimer’s disease.
Donate NowAlzheimer’s Association Statement on the Retirement of NIA Director Richard J. Hodes, M.D.
Hodes has led NIA since 1993, a tenure that spans a historic period in Alzheimer’s and dementia research. In that time, scientists have made biomarker discoveries, developed new diagnostics, gained a deeper understanding of the biology of the disease, advanced treatments and learned more about risk and risk reduction.
“Dr. Hodes led the NIA through the most consequential era in the history of Alzheimer’s and dementia research, and the Alzheimer’s Association was proud to work alongside him,” said Joanne Pike, DrPH, president and CEO of the Alzheimer’s Association. “His partnership helped change what is possible for people living with dementia, their care partners and their families. Thank you, Dr. Hodes. The next era is even more hopeful and we look forward to building on your legacy of leadership and discovery.”
When the National Alzheimer’s Project Act (NAPA), championed by the Alzheimer’s Association and the Alzheimer’s Impact Movement (AIM), passed in 2011, Hodes led expansion of NIA’s Alzheimer’s and related dementias research initiatives. He oversaw historic growth in Alzheimer’s and dementia research funding appropriated by Congress, which reached more than $3.9 billion annually in 2026. In 2020, he partnered with the National Institute of Neurological Disorders and Stroke to launch the NIH Center for Alzheimer’s and Related Dementias.
“Dr. Hodes was an essential partner to the scientific community as biomarkers moved from the lab toward the clinic, diagnostics advanced, treatments reached people and our understanding of the biology of Alzheimer’s and of risk and risk reduction grew,” said Maria Carrillo, Ph.D., chief science officer and medical affairs lead of the Alzheimer’s Association. “The science has never been more promising. We will keep driving it forward with the NIA and researchers around the world.”
About the Alzheimer's Association
The Alzheimer’s Association is a worldwide voluntary health organization dedicated to Alzheimer’s care, support and research. Our mission is to lead the way to end Alzheimer's and all other dementia — by accelerating global research, driving risk reduction and early detection, and maximizing quality care and support. Our vision is a world without Alzheimer's and all other dementia®. Visit alz.org or call 800.272.3900.
Alzheimer’s Impact Movement
The Alzheimer's Impact Movement (AIM) is a separately incorporated advocacy affiliate of the Alzheimer's Association. AIM works to develop and advance policies to overcome Alzheimer's disease through increased investment in research, enhanced care and improved support. For more information, visit alzimpact.org.